您要查找的是不是：
- Common in small cell lung cancer, adenocarcinoma type. 常见于小细胞肺癌、腺癌类型。
- VATS Lobectomy Is the Best Operation for Non-small Cell Lung Cancer? 胸腔镜肺切除术治疗肺部恶性肿瘤的合理性?
- Clinical effect of radiotherapy combined with GP regimen chemotherapy in advanced non- small cell lung cancer. 放疗加GP方案化疗治疗中晚期非小细胞肺癌疗效观察。
- Is prophylactic brain irradiation necessary after surgery and chemotherapy for small cell lung cancer? 小细胞肺癌术后化疗后预防性脑照射是否必要?
- Is there a role for combined modality therapy in early stage non-small cell lung cancer? 早期非小细胞肺癌多学科治疗的争议?
- Methods 62 advanced non-small cell lung cancer patients vithout surgical treatment were radomized into 2 groups with NP(NVB+DDP) and GP(GEM+DDP). 方法选择62例不能手术的晚期非小细胞肺癌病人,随机分为2组,分别采用NP(NVB+DDP)方案及GP(GEM+DDP)方案治疗。
- STUDY OBJECTIVES: Regional lymph node (LN) involvement affects the prognosis of patients with surgically resected non-small cell lung cancer (NSCLC). 目的：区域淋巴结（LN）情况影响手术切除非小细胞肺癌(NSCLC)患者的预后。
- Small cell lung cancer is neuroendocrine neoplasm and origins from APUD (amine precursor uptake decarboxylation)cell. 小细胞肺癌是神经内分泌肿瘤,起源于APUD(胺前体摄取脱羧化)细胞。
- Objective To discuss the correlation of CT appearances and the angiogenesis(VEGF,MVD) in small cell lung cancer(SCLC). 目的探讨小细胞肺癌(SCLC)的CT征象和血管内皮生长因子(VEGF)、微血管密度(MVD)的相关性。
- Most of them had stage III non-small cell lung cancer (NSCLC) (19/35) and received CCRT (18/35). 多数为第三期非小细胞肺癌(54%25,19/35)并接受同步化放疗(51%25,18/35)。
- Conclusion: Overexpression of ERK may play an important role in the development of human nonsmall cell lung cancer. 结论：ERK蛋白的过表达可能在非小细胞肺癌的发生、发展过程中起著重要的作用。
- Manegold C. Systemic therapy. In: Manegoed C, Allgayer H, Andreozzi A, eds. Non-Small Cell Lung Cancer Treatment. Ed1. 中国抗癌协会肺癌专业委员会.;中国肺癌临床指南
- For targeted biotherapy of Non-small cell lung cancer (NSCLC), the main emerging new drug is EGFR-inhibitor. 摘要非小细胞肺癌(NSCLC)生物靶点治疗药物主要是EGFR抑制剂。
- Monzo M, Rosell R, Taron M. Drug resistance in non small cell lung cancer. Lung Cancer,2001,34 Suppl 2 : S91-S94. [韩宝惠;廖美琳;苏建中;等.;非小细胞肺癌肿瘤药敏与耐药
- Objective To investigate the expression of osteopontin (OPN) in non-small cell lung cancer (NSCLC). 摘要目的研究骨桥蛋白(OPN)在非小细胞肺癌(NSCLC)中的表达。
- Objective: To evaluate the diagnostic significance of CT findings in small cell lung cancer (SCLC). 目的:探讨小细胞肺癌(SCLC)的CT表现与诊断。
- EGFR tyrosine kinase inhibitor is an investigative hot spot in targeted therapy of non-small cell lung cancer (NSCLC). 摘要EGFR靶向抑制剂，是目前NSCLC靶向治疗的研究热点之一。
- Objective To investigate the expression of osteopontin(OPN) in non-small cell lung cancer(NSCLC). 目的研究骨桥蛋白(OPN)在非小细胞肺癌(NSCLC)中的表达。
- To observe the effect and toxicity of topotecan in the treatment for small cell lung cancer(SCLC). 观察拓朴替康治疗小细胞肺癌的疗效和毒副反应。
- Advance in radiotherapy of non-small cell lung cancer(NSCLC) includes three aspects. 非小细胞肺癌(NSCLC)放射治疗的研究进展包括三个方面。
